Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Pharmeuropa. Special Issue Biologicals|November 27, 2002
Collaborative study for establishment of an HPLC-method for batch consistency control of recombinant interferon-alfa-2K H Buchheit, A Daas, K H Jönsson
Developments in Biologicals|April 8, 2003
A Vero cell method for potency testing of diphtheria vaccinesR Winsnes, D Sesardic, A Daas, et al.
Developments in Biologicals|April 8, 2003
Collaborative study for the establishment of a European Pharmacopoeia Biological Reference Preparation for Clostridia antiserum for serological potency testing of veterinary clostridial vaccinesR Lucken, A Daas, M E Behr-Gross
Pharmeuropa Bio|February 13, 2004
Collaborative study for establishment of a European Pharmacopoeia Biological Reference Preparation (BRP) for B19 virus DNA testing of plasma pools by nucleic acid amplification techniqueC M Nübling, A Daas, K H Buchheit
Pharmeuropa Bio|April 17, 2008
Collaborative study for the establishment of a candidate equine influenza subtype 2 American-like strain A/EQ/South Africa/4/03 - horse antiserum biological reference preparationJanet Daly, A Daas, M-E Behr-Gross
Pharmeuropa Bio & Scientific Notes|February 3, 2016
Collaborative study for the establishment of the 4(th) International Standard for StreptomycinS Jorajuria, C Raphalen, V Dujardin, et al.
Pharmeuropa Bio & Scientific Notes|August 11, 2016
Transferability study of CHO cell clustering assays for monitoring of pertussis toxin activity in acellular pertussis vaccinesR Isbrucker, A Daas, L Wagner, et al.
Pharmeuropa Bio & Scientific Notes|February 3, 2016
Collaborative study for the establishment of the 2(nd) International Standard for Bleomycin Complex A2/B2S Jorajuria, C Raphalen, V Dujardin, et al.
Pharmeuropa Bio|October 18, 2003
Establishment of European Pharmacopoeia BRP batch 2 for inactivated poliomyelitis vaccine for in vitro D antigen assayF Fuchs, P Minor, A Daas, et al.
Pharmeuropa Bio|October 18, 2003
Feasibility study to evaluate the correlation between results of a candidate in vitro assay and established in vivo assays for potency determination of Newcastle disease vaccinesI Claassen, R Maas, A Daas, et al.
Pageof 9